GlaxoSmithKline to Pay $460 Million to Avandia Plaintiffs
Philadelphia, PA: GlaxoSmithKline has reportedly agreed to pay $460 million to settle lawsuits alleging that diabetes medication Avandia caused an increased risk of heart attacks. News of the settlement comes as the US Food and Drug Administration (FDA) held an advisory panel to discuss Avandia side effects and determine what action, if any, to take on the drug. Avandia Legal Help If you have suffered losses in this case, please send your complaint to a lawyer who will review your possible [Avandia Lawsuit] at no cost or obligation.
ADD YOUR COMMENT ON THIS STORYClick to learn more about LawyersandSettlements.com |
|